Difference between revisions of "PMID:21185072"
(→References) |
(→References) |
||
Line 195: | Line 195: | ||
[[Category:Actinomycin D]] | [[Category:Actinomycin D]] | ||
[[Category:Amikacin]] | [[Category:Amikacin]] | ||
+ | [[Category:Ammonium Chloride]] | ||
[[Category:Amoxicillin]] | [[Category:Amoxicillin]] | ||
[[Category:Ampicillin]] | [[Category:Ampicillin]] | ||
Line 205: | Line 206: | ||
[[Category:Bile]] | [[Category:Bile]] | ||
[[Category:Bleomycin]] | [[Category:Bleomycin]] | ||
− | [[Category: | + | [[Category:Calcofluor]] |
[[Category:Carbenicillin]] | [[Category:Carbenicillin]] | ||
+ | [[Category:Carbonyl Cyanide 3-Chlorophenylhydrazone (CCCP)]] | ||
[[Category:Cecropin B]] | [[Category:Cecropin B]] | ||
[[Category:Cefaclor]] | [[Category:Cefaclor]] | ||
[[Category:Cefoxitin]] | [[Category:Cefoxitin]] | ||
− | [[Category: | + | [[Category:Cefsulodin]] |
+ | [[Category:Ceftazidime]] | ||
+ | [[Category:Cerulenin]] | ||
+ | [[Category:CHIR 090]] | ||
+ | [[Category:Chloramphenicol]] | ||
+ | [[Category:Chloropromazine]] | ||
+ | [[Category:Cholate]]Ciprofloxacin]] | ||
+ | [[Category:Cisplatin]] | ||
+ | [[Category:Clarythromycin]] | ||
+ | [[Category:Cycloserine D]] | ||
+ | [[Category:Deoxycholate]] | ||
+ | [[Category:Dibucaine]] | ||
+ | [[Category:Doxorubin]] | ||
+ | [[Category: | ||
+ | [[Category: | ||
+ | [[Category:Epinephrine]] | ||
+ | [[Category:Erythromycin]] | ||
+ | [[Category:Ethanol]] | ||
+ | [[Category:Ethidium Bromide]] | ||
+ | [[Category:Fosfomycin]] | ||
+ | [[Category:Fusidicacid]] | ||
+ | [[Category:Gentamycin]] | ||
+ | [[Category:Glucosamine]] | ||
+ | [[Category:Glucose]] | ||
+ | [[Category:Glufosfomycin]] | ||
+ | [[Category:Glycerol]] | ||
+ | [[Category:High Cobalt (Co)]] | ||
+ | [[Category:High Copper (Cu)]] | ||
+ | [[Category:High Iron (Fe)]] | ||
+ | [[Category:High Nickel (Ni)]] | ||
+ | [[Category:Hydroxyurea (HU)]] | ||
+ | [[Category:Indolicidin]] | ||
+ | [[Category:Isoniazid]] | ||
+ | [[Category:Levofloxacin]] | ||
+ | [[Category:Low Iron (Fe)]] | ||
+ | [[Category:Maltose]] | ||
+ | [[Category:Mecillinam]] | ||
+ | [[Category:Methotrexate]] | ||
+ | [[Category:Minocycline]] | ||
+ | [[Category:Mitomycin C]] | ||
+ | [[Category:MMS]] | ||
+ | [[Category:Nalidixic Acid]] | ||
+ | [[Category:High Sodium Chloride (NaCl)]] | ||
+ | [[Category:Nigericin]] | ||
+ | [[Category:Nitrofurantoin]] | ||
+ | [[Category:Norepinephrine]] | ||
+ | [[Category:Norfloxacin]] | ||
+ | [[Category:Novobiocin]] | ||
+ | [[Category:Oxacilliin]] | ||
+ | [[Category:Paraquat]] | ||
+ | [[Category:Peroxide]] | ||
+ | [[Category:pH]] | ||
+ | [[Category:Phleomycin]] | ||
+ | [[Category:PMS]] | ||
+ | [[Category:Polymyxin B]] | ||
+ | [[Category:Procaine]] | ||
+ | [[Category:Propidium Iodide]] | ||
+ | [[Category:Puromycin]] | ||
+ | [[Category:Pyocyanin]] | ||
+ | [[Category:Radicicol]] | ||
+ | [[Category:Rifampicin]] | ||
+ | [[Category:Spectinomycin]] | ||
+ | [[Category:Spiramycin]] | ||
+ | [[Category:Streptomycin]] | ||
+ | [[Category:Streptonigrin]] | ||
+ | [[Category:Succinate]] | ||
+ | [[Category:Sulfamethizole]] | ||
+ | [[Category:Sulfamonomethoxine]] | ||
+ | [[Category:Taurocholate]] | ||
+ | [[Category:Tetracycline]] | ||
+ | [[Category:Theophylline]] | ||
+ | [[Category:Thiolactomycin]] | ||
+ | [[Category:Tobramycin]] | ||
+ | [[Category:Triclosan]] | ||
+ | [[Category:Trimethoprim]] | ||
+ | [[Category:Trimethoprim-Sulfamethizole]] | ||
+ | [[Category:Triton X]] | ||
+ | [[Category:Tunicamycin]] | ||
+ | [[Category:Ultraviolet Radiation (UV)]] | ||
+ | [[Category:Vancomycin]] | ||
+ | [[Category:Verapamil]] |
Revision as of 14:38, 13 April 2011
Citation |
Nichols, RJ, Sen, S, Choo, YJ, Beltrao, P, Zietek, M, Chaba, R, Lee, S, Kazmierczak, KM, Lee, KJ, Wong, A, Shales, M, Lovett, S, Winkler, ME, Krogan, NJ, Typas, A and Gross, CA (2011) Phenotypic landscape of a bacterial cell.Cell 144:143-56 |
---|---|
Abstract |
The explosion of sequence information in bacteria makes developing high-throughput, cost-effective approaches to matching genes with phenotypes imperative. Using E. coli as proof of principle, we show that combining large-scale chemical genomics with quantitative fitness measurements provides a high-quality data set rich in discovery. Probing growth profiles of a mutant library in hundreds of conditions in parallel yielded > 10,000 phenotypes that allowed us to study gene essentiality, discover leads for gene function and drug action, and understand higher-order organization of the bacterial chromosome. We highlight new information derived from the study, including insights into a gene involved in multiple antibiotic resistance and the synergy between a broadly used combinatory antibiotic therapy, trimethoprim and sulfonamides. This data set, publicly available at http://ecoliwiki.net/tools/chemgen/, is a valuable resource for both the microbiological and bioinformatic communities, as it provides high-confidence associations between hundreds of annotated and uncharacterized genes as well as inferences about the mode of action of several poorly understood drugs. |
Links | |
Keywords |
phenotype; phenomic profiling; phenotypic signature; hierarchical clustering; responsive genome; high-throughput; chemical genomics; stress; essential; function; antibiotic resistance; synergy |
edit table |
Main Points of the Paper
- Key Motivation- provide phenotypes for mutants of genes without functional annotation
- Central Goal- systematically evaluate the impact of every gene deletion on E.coli fitness in diverse environments
- Phenomic Profiling- quantitative description of the response of all single-gene deletions to physiologically relevant stresses and drug challenges
- profiled ~4,000 genes in 324 conditions covering 114 unique stresses (more than half were antimicrobial/antibiotic stress)
- identified thousands of phenotypes
- identified a diverse set of conditionally essential genes
- Identified 116 rich-media conditionally essential (CE) genes
- facilitates high-confidence association of genes of unknown function to those of known function
- generates numerous leads concerning drug function
- Hierarchical clustering
- Phenotypic Signature- response of each mutant strain across all conditions
- high correlation b/t two phenotypic signatures implies a functional connection b/t genes
Materials and Methods Used
Strain Details
- Keio single-gene deletion library
- essential gene hypomorphs
- RNA/small protein knockout library
Equipment and Reagents
Procedure
Data Analysis
Hierarchical clustering
Phenotype Annotations
See Help:AnnotationTable for details on how to edit this table.
<protect>
Species | Taxon ID | Strain | Gene (if known) | OMP | Phenotype | Details | Evidence | Notes |
---|---|---|---|---|---|---|---|---|
Escherichia coli |
K-12 BW25113 |
ECK3620-RFAP |
sensitivity to 0.1% bile salts |
Growth |
slow growth |
Growth Curve |
rfaP phosphorylates core heptose of lipopolysaccharide | |
Escherichia coli |
K-12 BW25113 |
ECK0223-LPCA |
sensitivity to 1.2 mM DIBUCAINE |
Growth |
slow growth |
Growth Curve |
the target of DIBUCAINE is the membrane (pmf) | |
Escherichia coli |
K-12 BW25113 |
ECK3610-RFAF |
sensitivity to 0.1% bile salts |
Growth |
slow growth |
Growth Curve |
rfaF = ADP-heptose:LPS heptosyltransferase II target of bile salts: membrane | |
Escherichia coli |
K-12 BW25113 |
ECK3042-RFAE |
sensitivity to 30 µg/ml NOVOBIOCIN |
Growth |
slow growth |
Growth Curve |
ECK3042-RFAE = heptose 7-phosphate kinase/heptose 1-phosphate adenyltransferase the target of NOVOBIOCIN is DNA gyrase | |
Escherichia coli |
K-12 BW25113 |
ECK3610-RFAE |
sensitivity to 0.1% bile salts |
Growth |
slow growth |
Growth Curve |
ECK3042-RFAE = heptose 7-phosphate kinase/heptose 1-phosphate adenyltransferase target of bile salts: membrane
| |
edit table |
</protect>
Notes
References
See Help:References for how to manage references in omp dev. Ciprofloxacin]] [[Category: [[Category:
a
c
h
p
t